SciELO - Scientific Electronic Library Online

 
vol.135 número6Hepatocarcinoma con componente sarcomatoide: Caso clínicoÍndice de medicina preventiva: Una medida integradora de la cobertura de los programas preventivos índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

Compartir


Revista médica de Chile

versión impresa ISSN 0034-9887

Resumen

MIRANDA C, Marcelo  y  CASTIGLIONI T, Claudia. Aripiprazole for the treatment of Tourette syndrome. Experience in 10 patients. Rev. méd. Chile [online]. 2007, vol.135, n.6, pp.773-776. ISSN 0034-9887.  http://dx.doi.org/10.4067/S0034-98872007000600013.

Background: Tourette syndrome is a neuropsychiatric disorder characterized by motor and vocal tics, attentional deficit, poor control of impulses and obsessive compulsive disorder. Pharmacological treatment is often disappointing due to partial response and frequent poor tolerance to neuroleptic drugs which are otherwise the most effective therapy so far. Aim: To report a lasting improvement obtained with a new drug, aripiprazole that acts modulating both dopaminergic and serotoninergic neurotransmission. Material and methods: Ten patients refractory to their usual therapy, aged 10 to 35 years, were switched to aripiprazole in an open trial. Results: Nine of the 10 patients showed a significant response assessed by the Yale severity tics rating scale and the clinical global impression scale (p <0.01). No relevant adverse effects were observed. Conclusions: Aripiprazole may be a good pharmacological option for patients with Tourette syndrome

Palabras clave : Aripiprazole; Neurotransmitter agents; Tourette syndrome.

        · texto en Español     · Español ( pdf )

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons